Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 10/20 | 0.54 |
| ▸ | MEN1 | O00255 | 9/20 | 0.54 |
| ▸ | GAA | P10253 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 7/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.51 |
| ▸ | MYOC | Q99972 | 1/20 | 0.51 |
| ▸ | HTR1E | P28566 | 1/20 | 0.50 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.48 |
| ▸ | TGM2 | P21980 | 1/20 | 0.48 |
| ▸ | NAMPT | P43490 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1651305 | 0.99 | KMT2A (0.53) | KMT2AMEN1GAALMNAMAPT | |
| Hydrochloric Acid SCHEMBL11567226 | 0.99 | KMT2A (0.53) | KMT2AMEN1GAALMNAMAPT | |
| SCHEMBL987822 | 0.91 | KMT2A (0.61) | KMT2AMEN1GAALMNAMAPT | |
| SCHEMBL10914836 | 0.91 | KMT2A (0.61) | KMT2AMEN1GAALMNAMAPT | |
| SCHEMBL9259881 | 0.91 | KMT2A (0.61) | KMT2AMEN1GAALMNAMAPT | |
| SCHEMBL29629276 | 0.90 | MMP9 (0.47) | KMT2AMEN1GAALMNAMAPT | |
| Hydrochloric Acid SCHEMBL1895198 | 0.89 | KMT2A (0.59) | KMT2AMEN1GAALMNAMAPT | |
| SCHEMBL2681740 | 0.87 | KMT2A (0.56) | KMT2AMEN1GAALMNAMAPT | |
| SCHEMBL3692748 | 0.84 | ABCG2 (0.58) | KMT2AMEN1GAAMAPTALDH1A1 | |
| SCHEMBL6820632 | 0.83 | PDF (0.56) | KMT2AMEN1GAALMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119073578-A | Preparation method and application of water lily extract with anti-aging effect | 上海应用技术大学 | 2024-12-06 | — | — | CN | disclosed |
| CN-112137937-B | Active composition with skin aging delaying function and application thereof | 楚香(上海)生物科技有限公司 | 2023-05-02 | — | — | CN | disclosed |
| CN-107105707-B | Proline tolerant tripeptidylpeptidases and uses thereof | 杜邦营养生物科学有限公司 | 2022-07-22 | — | — | CN | disclosed |
| CN-114573682-A | Elastin peptide and preparation method thereof | 华南理工大学 | 2022-06-03 | — | — | CN | disclosed |
| EP-3914614-A1 | METHODS OF PRODUCING AND USING RECOMBINANT ALPHA 1-ANTITRYPSIN (AAT) AND COMPOSITIONS THEREOF | Excellgene SA (CH) | 2021-12-01 | — | — | EP | disclosed |
| EP-3694570-A1 | ELASTIN REDUCTION ALLOWING RECELLULARIZATION OF CARTILAGE IMPLANTS | Trauma Care Consult Traumatologische Forschung Gemeinnützige Gesellschaft mbH (AT) | 2020-08-19 | — | — | EP | disclosed |
| WO-2020152653-A1 | METHODS OF PRODUCING AND USING RECOMBINANT ALPHA 1-ANTITRYPSIN (AAT) AND COMPOSITIONS THEREOF | EXCELLGENE SA (CH) | 2020-07-30 | — | — | WO | disclosed |
| EP-3676329-A1 | BIODEGRADABLE POLYESTER ARTICLE COMPRISING ENZYMES | Carbiolice (FR) | 2020-07-08 | — | — | EP | disclosed |
| WO-2019073079-A1 | ELASTIN REDUCTION ALLOWING RECELLULARIZATION OF CARTILAGE IMPLANTS | NUERNBERGER SYLVIA (AT) | 2019-04-18 | — | — | WO | disclosed |
| WO-2019043134-A1 | BIODEGRADABLE POLYESTER ARTICLE COMPRISING ENZYMES | CARBIOLICE (FR) | 2019-03-07 | — | — | WO | disclosed |
| EP-1317555-B1 | RAT CATHEPSIN, DIPEPTIDYL PEPTIDASE I (DPPI): CRYSTAL STRUCTURE, INHIBITORS AND ITS USES | PROZYMEX AS (DK) | 2007-11-14 | — | — | EP | disclosed |
| US-20040043469-A1 | Dipeptidyl peptidase i crystal structure and its uses | PROZYMEX A/S (DK) | 2004-03-04 | — | — | US | disclosed |
| EP-1317555-A1 | RAT CATHEPSIN, DIPEPTIDYL PEPTIDASE I (DPPI): CRYSTAL STRUCTURE, INHIBITORS AND ITS USES | Prozymex A/S (DK) | 2003-06-11 | — | — | EP | disclosed |
| WO-2002020804-A1 | RAT CATHEPSIN, DIPEPTIDYL PEPTIDASE I (DPPI): CRYSTAL STRUCTURE, INHIBITORS AND ITS USES | PROZYMEX A/S (DK) | 2002-03-14 | — | — | WO | disclosed |
| EP-1042287-A1 | INDOLE DERIVATIVES AS INHIBITORS OF FACTOR XA | Aventis Pharma Deutschland GmbH (DE) | 2000-10-11 | — | — | EP | disclosed |
| US-6127144-A | PRODUCING HETEROLOGOUS PROTEINS BY INCUBATING STREPTOMYCES CELL TRANSFORMED WITH NUCLEIC ACID EXPRESSION CONSTRUCT IN PRESENCE OF PEPTIDE-SUSBSTITUTED CHLOROMETHYLKETONE AMINOPEPTIDASE INHIBITOR HAVING DEFINED STRUCTURE | CANGENE CORPORATION (CA) | 2000-10-03 | — | — | US | disclosed |
| WO-1999033800-A1 | INDOLE DERIVATIVES AS INHIBITORS OR FACTOR XA | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 1999-07-08 | — | — | WO | disclosed |
| EP-0758341-A1 | FACTOR Xa INHIBITORS | SELECTIDE CORPORATION (US) | 1997-02-19 | — | — | EP | disclosed |
| EP-0731841-A1 | PROTEASES FROM STREPTOMYCES AND USE THEREOF IN PROTEIN EXPRESSION SYSTEMS | Cangene Corporation (CA) | 1996-09-18 | — | — | EP | disclosed |
| WO-1995017512-A2 | PROTEASES FROM STREPTOMYCES AND USE THEREOF IN PROTEIN EXPRESSION SYSTEMS | CANGENE CORPORATION (CA) | 1995-06-29 | — | — | WO | disclosed |